Intrepid announced today that it served as the exclusive financial advisor to Apostrophe, a leading teledermatology platform, on its sale to Hims & Hers Health, Inc. (NYSE: HIMS) (Hims &… Read more »
Intrepid’s Healthcare Group was recently featured in finnCap Group’s global healthcare technology outlook (see attached) “How Smart Tech Is Changing Healthcare.” As the global healthcare industry emerges from the COVID-19… Read more »
Intrepid’s Joe Wisniewski, an Associate in the Healthcare Group, recently joined Scott Becker of McGuire Woods on Becker’s Private Equity podcast to discuss investment and innovation in the healthcare industry…. Read more »
M&A and investment activity in the urology sector has gained momentum over the past five years. Since Audax Group’s initial investment in Chesapeake Urology in August 2016, highly experienced multi-site… Read more »
The fertility services sector demonstrated remarkable resilience over the course of 2020 in the face of a global pandemic that disrupted nearly every aspect of the world as we know… Read more »
Transaction will fuel global expansion of Mosaic’s industry-leading multiplex immunohistochemistry services supporting targeted drug development Intrepid announced today that it served as the exclusive financial advisor to Mosaic Laboratories L.L.C…. Read more »
Intrepid congratulates Gary Rabishaw, Adam Abramowitz, and Brandon Quartararo for being selected by the Los Angeles Business Journal as “Leaders of Influence” in the Investment Bankers 2020 special issue. Gary… Read more »
The recent merger of Teladoc and Livongo is expected to accelerate the current explosion in digital health M&A and propel virtual services to become the “new normal”. Intrepid’s Healthcare and… Read more »
The pandemic is putting the diagnostics sector in the spotlight again. How have current events impacted the sector and what influence will they have on M&A and investment trends? Intrepid’s… Read more »